Addictions, Drug & Alcohol Institute

ADAI News & Events


March 10, 2026

CEDEER/SOR Webinar: What’s the Latest? Psychedelics for Opioid Use Disorder (March 30, 12pm PT)

ADAI webinar. What's the latest? Psychedelics for OPioid Use Disorder. Nathan Sackett, MD, MS. March 30, 2026, 12-1pm

Interest in the therapeutic use of psychedelics has grown rapidly in recent years—but what does the emerging research indicate about their role in treating opioid use disorder (OUD)? In this session, presented by Nathan Sackett, MD, MS, of ADAI’s Center for Novel Therapeutics in Addiction Psychiatry, we’ll explore the current evidence, potential mechanisms, safety considerations,…


March 9, 2026

CEDEER Webinar: Harm Reduction in All Directions: Supporting the Workforce (March 31, 11am PT)

Harm reduction in all directions: Supporting the workforce. CEDEER webinar. March 31, 2026, 11am-12pm PT

Harm reduction program staff serve an essential role in improving the health of people who use drugs. As front-line workers and first responders, they bring unique expertise and community connection to their work. However, their strengths and specialized needs are often overlooked. Join the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) on…


March 6, 2026

Upcoming CEDEER Webinars: Incorporating Lived/Living Experience into SUD Clinical Design – A 3-Part Series

Incorporating lived/living experience into SUD clinical design: a three-part series

ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research’s State Opioid Response team is hosting a 3-part series showcasing how incorporating lived and living experience can transform substance use disorder (SUD) clinical design. Hear from facilitators, healthcare professionals, and community members who shape community advisory boards (CABs) and lived experience advisory boards (LEABs). Speakers and…


March 5, 2026

RECORDING: Drugs Trends and Use Patterns & Service Utilization and Needs in Spokane County & WA State

Drug trends and use patterns & service utilization and needs in Spokane County and WA State - Caleb Banta-Green

ADAI Research Professor Caleb Banta-Green, PhD, MPH, MSW, recently presented with Samantha Carroll (Spokane Regional Health District Syringe Services Coordinator) at the February 2026 Spokane Regional Opioid Task Force meeting. Their presentation, “Drugs Trends, Use Patterns & Service Utilization and Needs in Spokane County and Washington State,” included information about different types of data and…


March 4, 2026

ADAI Lunch & Learn: Results from the 2025 WA State Syringe Services Program Health Survey (March 26, 2026, 12-1pm PT)

ADAI Lunch & Learn. Results from the 2025 WA State Syringe Services Program Health Survey. Alison Newman, MPH, UW ADAI. March 26, 2026, 12-1pm PT

What do people who receive services from syringe services programs (SSPs) have to say about their substance use patterns, health behaviors, and service use? What kinds of experiences have they had with healthcare, harm reduction, incarceration, and treatment? What care and services do they wish they could access? Join us on March 26, 2026 (12-1pm…


February 27, 2026

New ADAI Report: Evaluation of Seattle City Ordinance 126896 (Possession and Use of Controlled Substances in Public Spaces)

Stack of 3 binders with New ADAI Report on the spines

In late 2023, the City of Seattle passed Ordinance 126896, a law intended to reduce jail bookings for public drug use and possession by encouraging police to divert people to services instead of the criminal legal system. Researchers from the University of Washington’s Addictions, Drug & Alcohol Institute, led by Assistant Professor Mandy Owens, PhD,…


February 20, 2026

Northwest ATTC & CERP Webinar: Integrating Cannabis Use Prevention and Treatment into Primary Care (March 25, 12pm PT)

Northwest ATTC webinar March 25, 2026, 12pm PT: Integrating Cannabis Use Prevention and Treatment into Primary Care

Join the Northwest ATTC and the Cannabis Education & Research Program (CERP) at ADAI for this timely and informative webinar about cannabis! Integrating Cannabis Use Prevention and Treatment into Primary CareMarch 25, 2026 | 12-1pm PT | Register here Cannabis is one of the most widely used substances in the U.S., with notable rises in…


February 11, 2026

Northwest ATTC Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb. 25, 2026; CME available!)

ATTC/CTN Webinar Series: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl. February 25, 2026, 11am-12:30pm PT. 1.5 CME/CE Available.

Join the Northwest ATTC at ADAI, the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for their next joint webinar, February 25, 2026, 11am-12:30pm PT! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine…


February 10, 2026

RECORDING AVAILABLE: ADAI CEDEER Webinar: Franklin St. Harm Reduction Center: Community Partnerships in Olympia, WA

New CEDEER webinar: Franklin St. Harm Reduction Center: Community Partnerships in Olympia, Washington. February 23, 2026, 1-2pm PT

This webinar was hosted in February 2026. Find the recording here! Partnerships are powerful! Learn more about how community organizations came together to improve health in Olympia in the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER)‘s next webinar, February 23, 2026, 1-2pm PT. The Franklin St. Harm Reduction Center in Olympia, WA…


February 3, 2026

ADAI Lunch & Learn: Update on Neuromodulation Techniques and Applications (Feb. 26, 2026, 12pm PT)

ADAI Lunch and Learn: Update on Neuromodulation Techniques and Applications, Feb. 26, 2026, 12-1pm PT

Join ADAI on February 26, 2026 (12-1pm PT) for the next session in our (virtual) Lunch & Learn series! In this session, Randall Espinoza, MD, MPH, Medical Director of the UW Garvey Institute Center for Neuromodulation, will explore current FDA-approved neuromodulation devices—medical technologies that use electrical pulses, magnetic fields, or other techniques to treat various…



Next page